News Dec 07, 2022 Canada approves brain tumor therapy developed by Novocure Novocure has received authorization for its glioblastoma treatment on the Canadian market. Very few effective treatment options have so far been ...
News Oct 10, 2023 MSD commits to Lucerne as a business location MSD Switzerland has its sights set on further growth from its Lucerne location. Since being founded 60 years ago, the pharmaceutical company has ...
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News Sep 30, 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News Aug 25, 2020 Bloom Diagnostics raises capital for COVID-19 antibody tests The smart diagnosis system developed by Bloom Diagnostics is set to make COVID-19 antibody testing accessible to all. The test process takes just...
Export from Switzerland Global Opportunities Short-term market opportunities for Swiss SMEs: Use our new service and benefit from exciting export opportunities in selected industries and mar...
Global Network Offices around the world In collaboration with the Federal Department of Foreign Affairs (FDFA), we presently maintain offices in more than 25 countries.
News Jan 30, 2018 Cancer drug from Schachen The American pharmaceutical group MSD is producing a new cancer drug in Schachen, in Canton Lucerne.
News Jan 14, 2017 Switzerland is one of the happiest countries in the world Swiss cities continue to receive top marks when it comes to expatriate quality of living. According to the new quality-of-living rankings by Merc...